{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:14:09Z","timestamp":1767924849237,"version":"3.49.0"},"reference-count":145,"publisher":"Bentham Science Publishers Ltd.","issue":"17","funder":[{"DOI":"10.13039\/501100005632","name":"NCBR (Poland) Bilateral Cooperation program","doi-asserted-by":"publisher","award":["215S168"],"award-info":[{"award-number":["215S168"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>Alzheimer\u2019s disease is one of the leading health problems characterized\nby the accumulation of A\u03b2 and hyperphosphorylated tau that account for the senile\nplaque formations causing extensive cognitive decline. Many of the clinical diagnoses\nof Alzheimer\u2019s disease are made in the late stages, when the pathological changes\nhave already progressed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective::<\/jats:title>\n<jats:p> The objective of this study is to evaluate the promising therapeutic effects of a\nnatural compound, lycoramine, which has been shown to have therapeutic potential in\nseveral studies and to understand its mechanism of action on the molecular level via differential\nprotein expression analyses.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method::<\/jats:title>\n<jats:p>Lycoramine and galantamine, an FDA approved drug used in the treatment of\nmild to moderate AD, were administered to 12 month-old 5xFAD mice. Effects of the\ncompounds were investigated by Morris water maze, immunohistochemistry and label-\nfree differential protein expression analyses.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results::<\/jats:title>\n<jats:p>Here we demonstrated the reversal of cognitive decline via behavioral testing\nand the clearance of A\u03b2 plaques. Proteomics analysis provided in-depth information on\nthe statistically significant protein perturbations in the cortex, hippocampus and cerebellum\nsections to hypothesize the possible clearance mechanisms of the plaque formation\nand the molecular mechanism of the reversal of cognitive decline in a transgenic mouse\nmodel. Bioinformatics analyses showed altered molecular pathways that can be linked\nwith the reversal of cognitive decline observed after lycoramine administration but not\nwith galantamine.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p> Lycoramine shows therapeutic potential to halt and reverse cognitive decline\nat the late stages of disease progression, and holds great promise for the treatment of\nAlzheimer\u2019s disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867327999201116193126","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T09:56:49Z","timestamp":1605866209000},"page":"3449-3473","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer\u2019s Disease in Mouse Model"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0958-114X","authenticated-orcid":true,"given":"Irem","family":"Kiris","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6460-4151","authenticated-orcid":true,"given":"Merve Karayel","family":"Basar","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-5741","authenticated-orcid":true,"given":"Betul","family":"Sahin","sequence":"additional","affiliation":[{"name":"Acibadem Labmed Clinical Laboratories, R&amp;D Center, Istanbul,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-1467","authenticated-orcid":true,"given":"Busra","family":"Gurel","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-6738","authenticated-orcid":true,"given":"Julide","family":"Coskun","sequence":"additional","affiliation":[{"name":"Acibadem Labmed Clinical Laboratories, R&amp;D Center, Istanbul,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-7182","authenticated-orcid":true,"given":"Tomasz","family":"Mroczek","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Medical University of Lublin, Lublin,Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-7351","authenticated-orcid":true,"given":"Ahmet Tarik","family":"Baykal","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul,Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"1","author":"Christina P.","year":"2018","unstructured":"Christina P.; World Alzheimer\u2019s Report 2018. Available at:\n (Accessed date: 14.01.2020).2018,1-48"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3389\/fphar.2018.01192","volume":"9","author":"Dos Santos T.C.","year":"2018","unstructured":"Dos Santos T.C.; Gomes T.M.; Pinto B.A.S.; Camara A.L.; Paes A.M.A.; Naturally occurring acetylcholinesterase inhibitors and their potential use for alzheimer\u2019s disease therapy. Front Pharmacol 2018,9,1192","journal-title":"Front Pharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0163-7258(00)00081-4","volume":"88","author":"Yamada K.","year":"2000","unstructured":"Yamada K.; Nabeshima T.; Animal models of Alzheimer\u2019s disease and evaluation of anti-dementia drugs. Pharmacol Ther 2000,88(2),93-113","journal-title":"Pharmacol Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"CD001747","DOI":"10.1002\/14651858.CD001747.pub3","volume":"1","author":"Loy C.","year":"2006","unstructured":"Loy C.; Schneider L.; Galantamine for Alzheimer\u2019s disease and mild cognitive impairment. Cochrane Database Syst Rev 2006,1(1),CD001747","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1474-4422(08)70261-8","volume":"8","author":"Burns A.","year":"2009","unstructured":"Burns A.; Bernabei R.; Bullock R.; Cruz Jentoft A.J.; Fr&#xF6;lich L.; Hock C.; Raivio M.; Triau E.; Vandewoude M.; Wimo A.; Came E.; Van Baelen B.; Hammond G.L.; van Oene J.C.; Schwalen S.; Safety and efficacy of galantamine (Reminyl) in severe Alzheimer\u2019s disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. Lancet Neurol 2009,8(1),39-47","journal-title":"Lancet Neurol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","volume":"70","author":"Winblad B.","year":"2008","unstructured":"Winblad B.; Gauthier S.; Scinto L.; Feldman H.; Wilcock G.K.; Truyen L.; Mayorga A.J.; Wang D.; Brashear H.R.; Nye J.S.; Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology 2008,70(22),2024-2035","journal-title":"Neurology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1503\/cmaj.130451","volume":"185","author":"Tricco A.C.","year":"2013","unstructured":"Tricco A.C.; Soobiah C.; Berliner S.; Ho J.M.; Ng C.H.; Ashoor H.M.; Chen M.H.; Hemmelgarn B.; Straus S.E.; Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ 2013,185(16),1393-1401","journal-title":"CMAJ"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.4103\/1673-5374.249228","volume":"14","author":"Jin B.R.","year":"2019","unstructured":"Jin B.R.; Liu H.Y.; Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: systematic review and Bayesian network meta-analysis. Neural Regen Res 2019,14(5),805-816","journal-title":"Neural Regen Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","volume":"321","author":"Wilcock G.K.","year":"2000","unstructured":"Wilcock G.K.; Lilienfeld S.; Gaens E.; Efficacy and safety of galantamine in patients with mild to moderate Alzheimer\u2019s disease: multicentre randomised controlled trial. Galantamine International-1 Study Group. BMJ 2000,321(7274),1445-1449","journal-title":"BMJ"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuint.2015.07.018","volume":"89","author":"Ng Y.P.","year":"2015","unstructured":"Ng Y.P.; Or T.C.T.; Ip N.Y.; Plant alkaloids as drug leads for Alzheimer\u2019s disease. Neurochem Int 2015,89,260-270","journal-title":"Neurochem Int"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12272-013-0188-1","volume":"37","author":"Jin A.","year":"2014","unstructured":"Jin A.; Li X.; Zhu Y.Y.; Yu H.Y.; Pi H.F.; Zhang P.; Ruan H.L.; Four new compounds from the bulbs of Lycoris aurea with neuroprotective effects against CoCl and HO-induced SH-SYY cell injuries. Arch Pharm Res 2014,37(3),315-323","journal-title":"Arch Pharm Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jpba.2012.08.001","volume":"71","author":"Katoch D.","year":"2012","unstructured":"Katoch D.; Kumar S.; Kumar N.; Singh B.; Simultaneous quantification of Amaryllidaceae alkaloids from Zephyranthes grandiflora by UPLC-DAD\/ESI-MS\/MS. J Pharm Biomed Anal 2012,71,187-192","journal-title":"J Pharm Biomed Anal"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/14786419.2019.1598989","volume":"35","author":"Shawky E.","year":"2021","unstructured":"Shawky E.; El Sohafy S.M.; de Andrade J.P.; de Souza Borges W.; Profiling of acetylcholinesterase inhibitory alkaloids from some Crinum, Habranthus and Zephyranthes species by GC-MS combined with multivariate analyses and in silico studies. Nat Prod Res 2021,35(5),807-814","journal-title":"Nat Prod Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jpba.2014.09.022","volume":"102","author":"Cortes N.","year":"2015","unstructured":"Cortes N.; Alvarez R.; Osorio E.H.; Alzate F.; Berkov S.; Osorio E.; Alkaloid metabolite profiles by GC\/MS and acetylcholinesterase inhibitory activities with binding- mode predictions of five Amaryllidaceae plants. J Pharm Biomed Anal 2015,102,222-228","journal-title":"J Pharm Biomed Anal"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.chroma.2009.01.061","volume":"1216","author":"Mroczek T.","year":"2009","unstructured":"Mroczek T.; Highly efficient, selective and sensitive molecular screening of acetylcholinesterase inhibitors of natural origin by solid-phase extraction-liquid chromatography\/electrospray ionisation-octopole-orthogonal acceleration time-of-flight-mass spectrometry and novel thin-layer chromatography-based bioautography. J Chromatogr A 2009,1216(12),2519-2528","journal-title":"J Chromatogr A"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"Oakley H.","year":"2006","unstructured":"Oakley H.; Cole S.L.; Logan S.; Maus E.; Shao P.; Craft J.; Guillozet-Bongaarts A.; Ohno M.; Disterhoft J.; Van Eldik L.; Berry R.; Vassar R.; Intraneuronal &#x3B2;-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006,26(40),10129-10140","journal-title":"J Neurosci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/BCI.S13025","volume":"6","author":"Maarouf C.L.","year":"2013","unstructured":"Maarouf C.L.; Kokjohn T.A.; Whiteside C.M.; Macias M.P.; Kalback W.M.; Sabbagh M.N.; Beach T.G.; Vassar R.; Roher A.E.; Molecular differences and similarities between Alzheimer\u2019s disease and the 5XFAD transgenic mouse model of amyloidosis. Biochem Insights 2013,6,1-10","journal-title":"Biochem Insights"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbr.2017.09.009","volume":"337","author":"O\u2019Leary T.P.","year":"2018","unstructured":"O\u2019Leary T.P.; Robertson A.; Chipman P.H.; Rafuse V.F.; Brown R.E.; Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer\u2019s disease. Behav Brain Res 2018,337,256-263","journal-title":"Behav Brain Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3233\/JAD-170329","volume":"61","author":"Gurel B.","year":"2018","unstructured":"Gurel B.; Cansev M.; Sevinc C.; Kelestemur S.; Ocalan B.; Cakir A.; Aydin S.; Kahveci N.; Ozansoy M.; Taskapilioglu O.; Ulus I.H.; Ba&#x15F;ar M.K.; Sahin B.; Tuzuner M.B.; Baykal A.T.; Early stage alterations in CA1 extracellular region proteins indicate dysregulation of IL6 and iron homeostasis in the 5XFAD Alzheimer\u2019s disease mouse model. J Alzheimers Dis 2018,61(4),1399-1410","journal-title":"J Alzheimers Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"196.e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"Jawhar S.","year":"2012","unstructured":"Jawhar S.; Trawicka A.; Jenneckens C.; Bayer T.A.; Wirths O.; Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A&#x3B2; aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging 2012,33(1),196.e29-196.e40","journal-title":"Neurobiol Aging"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jpba.2016.06.048","volume":"129","author":"Mroczek T.","year":"2016","unstructured":"Mroczek T.; Qualitative and quantitative two-dimensional thin-layer chromatography\/high performance liquid chromatography\/diode-array\/electrospray-ionization-time-of-flight mass spectrometry of cholinesterase inhibitors. J Pharm Biomed Anal 2016,129,155-162","journal-title":"J Pharm Biomed Anal"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"392324","DOI":"10.1155\/2014\/392324","volume":"2014","author":"Li Z.","year":"2014","unstructured":"Li Z.; Liu Y.; Wang L.; Liu X.; Chang Q.; Guo Z.; Liao Y.; Pan R.; Fan T.P.; Memory-enhancing effects of the crude extract of Polygala tenuifolia on aged mice. Evid Based Complement Alternat Med 2014,2014,392324","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"Wi&#x15B;niewski J.R.","year":"2009","unstructured":"Wi&#x15B;niewski J.R.; Zougman A.; Nagaraj N.; Mann M.; Universal sample preparation method for proteome analysis. Nat Methods 2009,6(5),359-362","journal-title":"Nat Methods"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jproteome.7b00464","volume":"17","author":"Moseley M.A.","year":"2018","unstructured":"Moseley M.A.; Hughes C.J.; Juvvadi P.R.; Soderblom E.J.; Lennon S.; Perkins S.R.; Thompson J.W.; Steinbach W.J.; Geromanos S.J.; Wildgoose J.; Langridge J.I.; Richardson K.; Vissers J.P.C.; Scanning quadrupole data-independent acquisition, part a: qualitative and quantitative characterization. J Proteome Res 2018,17(2),770-779","journal-title":"J Proteome Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12021-016-9303-z","volume":"14","author":"Guly&#xE1;s M.","year":"2016","unstructured":"Guly&#xE1;s M.; Bencsik N.; Pusztai S.; Liliom H.; Schlett K.; Animal tracker: an imagej-based tracking API to create a customized behaviour analyser program. Neuroinformatics 2016,14(4),479-481","journal-title":"Neuroinformatics"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"Huang W.","year":"2009","unstructured":"Huang W.; Sherman B.T.; Lempicki R.A.; Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009,37(1),1-13","journal-title":"Nucleic Acids Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"Huang W.","year":"2009","unstructured":"Huang W.; Sherman B.T.; Lempicki R.A.; Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,4(1),44-57","journal-title":"Nat Protoc"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"W566-70","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"Metsalu T.","year":"2015","unstructured":"Metsalu T.; Vilo J.; ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res 2015,43(W1),W566-70","journal-title":"Nucleic Acids Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1172\/JCI6179","volume":"103","author":"Holtzman D.M.","year":"1999","unstructured":"Holtzman D.M.; Bales K.R.; Wu S.; Bhat P.; Parsadanian M.; Fagan A.M.; Chang L.K.; Sun Y.; Paul S.M.; Expression of human apolipoprotein E reduces amyloid-&#x3B2; deposition in a mouse model of Alzheimer\u2019s disease. J Clin Invest 1999,103(6),R15-R21","journal-title":"J Clin Invest"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1750-3639.1993.tb00724.x","volume":"3","author":"Kosik K.S.","year":"1993","unstructured":"Kosik K.S.; The molecular and cellular biology of tau. Brain Pathol 1993,3(1),39-43","journal-title":"Brain Pathol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"fcz003","DOI":"10.1093\/braincomms\/fcz003","volume":"1","author":"Jackson R.J.","year":"2019","unstructured":"Jackson R.J.; Rose J.; Tulloch J.; Henstridge C.; Smith C.; Spires-Jones T.L.; Clusterin accumulates in synapses in Alzheimer\u2019s disease and is increased in apolipoprotein E4 carriers. Brain Commun 2019,1(1),fcz003","journal-title":"Brain Commun"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.exger.2015.10.015","volume":"72","author":"Wu Z.","year":"2015","unstructured":"Wu Z.; Zhao L.; Chen X.; Cheng X.; Zhang Y.; Galantamine attenuates amyloid-&#x3B2; deposition and astrocyte activation in APP\/PS1 transgenic mice. Exp Gerontol 2015,72,244-250","journal-title":"Exp Gerontol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/jm7009364","volume":"51","author":"Cavalli A.","year":"2008","unstructured":"Cavalli A.; Bolognesi M.L.; M&#xEC;narini A.; Rosini M.; Tumiatti V.; Recanatini M.; Melchiorre C.; Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008,51(3),347-372","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1006\/jmbi.1997.1245","volume":"272","author":"Alvarez A.","year":"1997","unstructured":"Alvarez A.; Opazo C.; Alarc&#xF3;n R.; Garrido J.; Inestrosa N.C.; Acetylcholinesterase promotes the aggregation of amyloid-&#x3B2;-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 1997,272(3),348-361","journal-title":"J Mol Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0928-4257(99)80002-3","volume":"92","author":"Inestrosa N.C.","year":"1998","unstructured":"Inestrosa N.C.; Alarc&#xF3;n R.; Molecular interactions of acetylcholinesterase with senile plaques. J Physiol Paris 1998,92(5-6),341-344","journal-title":"J Physiol Paris"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.1021\/bi0101392","volume":"40","author":"De Ferrari G.V.","year":"2001","unstructured":"De Ferrari G.V.; Canales M.A.; Shin I.; Weiner L.M.; Silman I.; Inestrosa N.C.; A structural motif of acetylcholinesterase that promotes amyloid &#x3B2;-peptide fibril formation. Biochemistry 2001,40(35),10447-10457","journal-title":"Biochemistry"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trci.2018.11.004","volume":"5","author":"Sabbagh M.N.","year":"2019","unstructured":"Sabbagh M.N.; Hendrix S.; Harrison J.E.; FDA position statement &#x201C;Early Alzheimer\u2019s disease: Developing drugs for treatment, Guidance for Industry&#x201D;. Alzheimers Dement (N Y) 2019,5,13-19","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=38","unstructured":"Drug approval package, F.D.A. 2020 Available at:\n (Accessed date: 18.03.2020)."},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","volume":"8","author":"Lilienfeld S.","year":"2002","unstructured":"Lilienfeld S.; Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer\u2019s disease. CNS Drug Rev 2002,8(2),159-176","journal-title":"CNS Drug Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1515\/znc-2010-7-807","volume":"65","author":"Mu H.M.","year":"2010","unstructured":"Mu H.M.; Wang R.; Li X.D.; Jiang Y.M.; Peng F.; Xia B.; Alkaloid accumulation in different parts and ages of Lycoris chinensis.\n Z Natforsch C J Biosci 2010,65(7-8),458-462","journal-title":"Z Natforsch C J Biosci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1016\/j.bmcl.2012.08.005","volume":"22","author":"Nair J.J.","year":"2012","unstructured":"Nair J.J.; R&#xE1;rov&#xE1; L.; Strnad M.; Bastida J.; van Staden J.; Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae.\n Bioorg Med Chem Lett 2012,22(19),6195-6199","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"Sasaguri H.","year":"2017","unstructured":"Sasaguri H.; Nilsson P.; Hashimoto S.; Nagata K.; Saito T.; De Strooper B.; Hardy J.; Vassar R.; Winblad B.; Saido T.C.; APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J 2017,36(17),2473-2487","journal-title":"EMBO J"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12906-016-1033-0","volume":"16","author":"Park J-C.","year":"2016","unstructured":"Park J-C.; Ma J.; Jeon W.K.; Han J-S.; \nFructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice. BMC Complement Altern Med 2016,16,54","journal-title":"BMC Complement Altern Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"22768","DOI":"10.1074\/jbc.M200164200","volume":"277","author":"Dineley K.T.","year":"2002","unstructured":"Dineley K.T.; Xia X.; Bui D.; Sweatt J.D.; Zheng H.; Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 2002,277(25),22768-22780","journal-title":"J Biol Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/ptr.3183","volume":"24","author":"Urano T.","year":"2010","unstructured":"Urano T.; Tohda C.; Icariin improves memory impairment in Alzheimer\u2019s disease model mice (5xFAD) and attenuates amyloid &#x3B2;-induced neurite atrophy. Phytother Res 2010,24(11),1658-1663","journal-title":"Phytother Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"10298","DOI":"10.1074\/jbc.M112.415141","volume":"288","author":"Wang D.","year":"2013","unstructured":"Wang D.; Fu Q.; Zhou Y.; Xu B.; Shi Q.; Igwe B.; Matt L.; Hell J.W.; Wisely E.V.; Oddo S.; Xiang Y.K.; &#x3B2;2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models. J Biol Chem 2013,288(15),10298-10307","journal-title":"J Biol Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","volume":"135","author":"Schneider F.","year":"2014","unstructured":"Schneider F.; Baldauf K.; Wetzel W.; Reymann K.G.; Behavioral and EEG changes in male 5xFAD mice. Physiol Behav 2014,135,25-33","journal-title":"Physiol Behav"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnagi.2014.00075","volume":"6","author":"Bouter Y.","year":"2014","unstructured":"Bouter Y.; Kacprowski T.; Weissmann R.; Dietrich K.; Borgers H.; Brau&#xDF; A.; Sperling C.; Wirths O.; Albrecht M.; Jensen L.R.; Kuss A.W.; Bayer T.A.; Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer\u2019s disease by deep sequencing. Front Aging Neurosci 2014,6,75","journal-title":"Front Aging Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1326-9-33","volume":"9","author":"Landel V.","year":"2014","unstructured":"Landel V.; Baranger K.; Virard I.; Loriod B.; Khrestchatisky M.; Rivera S.; Benech P.; F&#xE9;ron F.; Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer\u2019s disease. Mol Neurodegener 2014,9,33","journal-title":"Mol Neurodegener"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3727\/000000007783464759","volume":"16","author":"French K.L.","year":"2007","unstructured":"French K.L.; Bimonte-Nelson H.A.; Granholm A.C.; Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats. Cell Transplant 2007,16(3),197-205","journal-title":"Cell Transplant"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/jpet.105.093047","volume":"316","author":"Hernandez C.M.","year":"2006","unstructured":"Hernandez C.M.; Gearhart D.A.; Parikh V.; Hohnadel E.J.; Davis L.W.; Middlemore M.L.; Warsi S.P.; Waller J.L.; Terry A.V.Jr.; Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats. J Pharmacol Exp Ther 2006,316(2),679-694","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0306-4522(00)00180-9","volume":"99","author":"Barnes C.A.","year":"2000","unstructured":"Barnes C.A.; Meltzer J.; Houston F.; Orr G.; McGann K.; Wenk G.L.; Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 2000,99(1),17-23","journal-title":"Neuroscience"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e89454","DOI":"10.1371\/journal.pone.0089454","volume":"9","author":"Bhattacharya S.","year":"2014","unstructured":"Bhattacharya S.; Haertel C.; Maelicke A.; Montag D.; Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer\u2019s disease. PLoS One 2014,9(2),e89454","journal-title":"PLoS One"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4062\/biomolther.2010.18.1.065","volume":"18","author":"Lee N.Y.","year":"2010","unstructured":"Lee N.Y.; Kang Y.S.; The inhibitory effect of rivastigmine and galantamine on choline transport in brain capillary endothelial cells. Biomol Ther (Seoul) 2010,18(1),65-70","journal-title":"Biomol Ther (Seoul)"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2009.01.024","volume":"280","author":"Matharu B.","year":"2009","unstructured":"Matharu B.; Gibson G.; Parsons R.; Huckerby T.N.; Moore S.A.; Cooper L.J.; Millichamp R.; Allsop D.; Austen B.; Galantamine inhibits &#x3B2;-amyloid aggregation and cytotoxicity. J Neurol Sci 2009,280(1-2),49-58","journal-title":"J Neurol Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"40180","DOI":"10.1074\/jbc.M110.142356","volume":"285","author":"Takata K.","year":"2010","unstructured":"Takata K.; Kitamura Y.; Saeki M.; Terada M.; Kagitani S.; Kitamura R.; Fujikawa Y.; Maelicke A.; Tomimoto H.; Taniguchi T.; Shimohama S.; Galantamine-induced amyloid-&#x3B2; clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J Biol Chem 2010,285(51),40180-40191","journal-title":"J Biol Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"Foster E.M.","year":"2019","unstructured":"Foster E.M.; Dangla-Valls A.; Lovestone S.; Ribe E.M.; Buckley N.J.; Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 2019,13,164","journal-title":"Front Neurosci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3940(99)00496-6","volume":"271","author":"Grewal R.P.","year":"1999","unstructured":"Grewal R.P.; Morgan T.E.; Finch C.E.; C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis. Neurosci Lett 1999,271(1),65-67","journal-title":"Neurosci Lett"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/2051-5960-2-53","volume":"2","author":"Ingram G.","year":"2014","unstructured":"Ingram G.; Loveless S.; Howell O.W.; Hakobyan S.; Dancey B.; Harris C.L.; Robertson N.P.; Neal J.W.; Morgan B.P.; Complement activation in multiple sclerosis plaques: an immunohistochemical analysis. Acta Neuropathol Commun 2014,2,53","journal-title":"Acta Neuropathol Commun"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00401-002-0546-4","volume":"104","author":"Sasaki K.","year":"2002","unstructured":"Sasaki K.; Doh-ura K.; Wakisaka Y.; Iwaki T.; Clusterin\/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with &#x3B1;-synucleinopathies. Acta Neuropathol 2002,104(3),225-230","journal-title":"Acta Neuropathol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"Labadorf A.","year":"2015","unstructured":"Labadorf A.; Hoss A.G.; Lagomarsino V.; Latourelle J.C.; Hadzi T.C.; Bregu J.; MacDonald M.E.; Gusella J.F.; Chen J.F.; Akbarian S.; Weng Z.; Myers R.H.; RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS One 2015,10(12),e0143563","journal-title":"PLoS One"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","volume":"5","author":"May P.C.","year":"1990","unstructured":"May P.C.; Lampert-Etchells M.; Johnson S.A.; Poirier J.; Masters J.N.; Finch C.E.; Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer\u2019s disease and in response to experimental lesions in rat. Neuron 1990,5(6),831-839","journal-title":"Neuron"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","volume":"111","author":"Martins I.J.","year":"2009","unstructured":"Martins I.J.; Berger T.; Sharman M.J.; Verdile G.; Fuller S.J.; Martins R.N.; Cholesterol metabolism and transport in the pathogenesis of Alzheimer\u2019s disease. J Neurochem 2009,111(6),1275-1308","journal-title":"J Neurochem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"DeMattos R.B.","year":"2002","unstructured":"DeMattos R.B.; O\u2019dell M.A.; Parsadanian M.; Taylor J.W.; Harmony J.A.K.; Bales K.R.; Paul S.M.; Aronow B.J.; Holtzman D.M.; Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 2002,99(16),10843-10848","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","volume":"96","author":"Bales K.R.","year":"1999","unstructured":"Bales K.R.; Verina T.; Cummins D.J.; Du Y.; Dodel R.C.; Saura J.; Fishman C.E.; DeLong C.A.; Piccardo P.; Petegnief V.; Ghetti B.; Paul S.M.; Apolipoprotein E.; Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 1999,96(26),15233-15238","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"Koistinaho M.","year":"2004","unstructured":"Koistinaho M.; Lin S.; Wu X.; Esterman M.; Koger D.; Hanson J.; Higgs R.; Liu F.; Malkani S.; Bales K.R.; Paul S.M.; Apolipoprotein E.; Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-&#x3B2; peptides. Nat Med 2004,10(7),719-726","journal-title":"Nat Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"Bales K.R.","year":"1997","unstructured":"Bales K.R.; Verina T.; Dodel R.C.; Du Y.; Altstiel L.; Bender M.; Hyslop P.; Johnstone E.M.; Little S.P.; Cummins D.J.; Piccardo P.; Ghetti B.; Paul S.M.; Lack of apolipoprotein E dramatically reduces amyloid &#x3B2;-peptide deposition. Nat Genet 1997,17(3),263-264","journal-title":"Nat Genet"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaneurol.2014.2011","volume":"71","author":"Mak A.C.Y.","year":"2014","unstructured":"Mak A.C.Y.; Pullinger C.R.; Tang L.F.; Wong J.S.; Deo R.C.; Schwarz J-M.; Gugliucci A.; Movsesyan I.; Ishida B.Y.; Chu C.; Poon A.; Kim P.; Stock E.O.; Schaefer E.J.; Asztalos B.F.; Castellano J.M.; Wyss-Coray T.; Duncan J.L.; Miller B.L.; Kane J.P.; Kwok P-Y.; Malloy M.J.; Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function. JAMA Neurol 2014,71(10),1228-1236","journal-title":"JAMA Neurol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4172\/2161-0460.1000209","volume":"6","author":"Gottschalk W.K.","year":"2016","unstructured":"Gottschalk W.K.; Mihovilovic M.; Roses A.D.; Chiba-Falek O.; The role of upregulated APOE in Alzheimer\u2019s disease etiology. J Alzheimers Dis Parkinsonism 2016,6(1),209","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"ref=70","year":"2020","unstructured":"JacksonLab. 5XFAD. Available at:\n (Accessed date: 03.03.2020).2020"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/ADR-170049","volume":"2","author":"Mazi A.R.","year":"2018","unstructured":"Mazi A.R.; Arzuman A.S.; Gurel B.; Sahin B.; Tuzuner M.B.; Ozansoy M.; Baykal A.T.; Neonatal neurodegeneration in Alzheimer\u2019s disease transgenic mouse model. J Alzheimers Dis.\n J Alzheimers Dis Rep 2018,2(1),79-91","journal-title":"J Alzheimers Dis Rep"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41598-018-37312-0","volume":"9","author":"Creighton S.D.","year":"2019","unstructured":"Creighton S.D.; Mendell A.L.; Palmer D.; Kalisch B.E.; MacLusky N.J.; Prado V.F.; Prado M.A.M.; Winters B.D.; Dissociable cognitive impairments in two strains of transgenic Alzheimer\u2019s disease mice revealed by a battery of object-based tests. Sci Rep 2019,9(1),57","journal-title":"Sci Rep"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.bbr.2014.08.034","volume":"274","author":"Kanno T.","year":"2014","unstructured":"Kanno T.; Tsuchiya A.; Nishizaki T.; Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice. Behav Brain Res 2014,274,302-306","journal-title":"Behav Brain Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnbeh.2018.00273","volume":"12","author":"Kang S.","year":"2018","unstructured":"Kang S.; Ha S.; Park H.; Nam E.; Suh W.H.; Suh Y.H.; Chang K.A.; Effects of a dehydroevodiamine-derivative on synaptic destabilization and memory impairment in the 5xFAD, Alzheimer\u2019s disease mouse model. Front Behav Neurosci 2018,12,273","journal-title":"Front Behav Neurosci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"664","DOI":"10.18632\/aging.100906","volume":"8","author":"Gri&#xF1;&#xE1;n-Ferr&#xE9; C.","year":"2016","unstructured":"Gri&#xF1;&#xE1;n-Ferr&#xE9; C.; Sarroca S.; Ivanova A.; Puigoriol-Illamola D.; Aguado F.; Camins A.; Sanfeliu C.; Pall&#xE0;s M.; Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice. Aging (Albany NY) 2016,8(4),664-684","journal-title":"Aging (Albany NY)"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"Roberson E.D.","year":"2007","unstructured":"Roberson E.D.; Scearce-Levie K.; Palop J.J.; Yan F.; Cheng I.H.; Wu T.; Gerstein H.; Yu G.Q.; Mucke L.; Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science 2007,316(5825),750-754","journal-title":"Science"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fnins.2019.00735","volume":"13","author":"Jackson J.","year":"2019","unstructured":"Jackson J.; Jambrina E.; Li J.; Marston H.; Menzies F.; Phillips K.; Gilmour G.; Targeting the synapse in Alzheimer\u2019s disease. Front Neurosci 2019,13,735","journal-title":"Front Neurosci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","volume":"78","author":"Davies C.A.","year":"1987","unstructured":"Davies C.A.; Mann D.M.A.; Sumpter P.Q.; Yates P.O.; A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer\u2019s disease. J Neurol Sci 1987,78(2),151-164","journal-title":"J Neurol Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"Selkoe D.J.","year":"2002","unstructured":"Selkoe D.J.; Alzheimer\u2019s disease is a synaptic failure. Science 2002,298(5594),789-791","journal-title":"Science"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"10071","DOI":"10.1073\/pnas.1204606109","volume":"109","author":"Limon A.","year":"2012","unstructured":"Limon A.; Reyes-Ruiz J.M.; Miledi R.; Loss of functional GABA(A) receptors in the Alzheimer diseased brain. Proc Natl Acad Sci USA 2012,109(25),10071-10076","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/jnc.14325","volume":"145","author":"Kwakowsky A.","year":"2018","unstructured":"Kwakowsky A.; Calvo-Flores Guzm&#xE1;n B.; Pandya M.; Turner C.; Waldvogel H.J.; Faull R.L.; GABA receptor subunit expression changes in the human Alzheimer\u2019s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus. J Neurochem 2018,145(5),374-392","journal-title":"J Neurochem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1002\/ajmg.a.36714","volume":"164A","author":"Srivastava S.","year":"2014","unstructured":"Srivastava S.; Cohen J.; Pevsner J.; Aradhya S.; McKnight D.; Butler E.; Johnston M.; Fatemi A.; A novel variant in GABRB associated with intellectual disability and epilepsy. Am J Med Genet A 2014,164A(11),2914-2921","journal-title":"Am J Med Genet A"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/ncomms1565","volume":"2","author":"Niesmann K.","year":"2011","unstructured":"Niesmann K.; Breuer D.; Brockhaus J.; Born G.; Wolff I.; Reissner C.; Kilimann M.W.; Rohlmann A.; Missler M.; Dendritic spine formation and synaptic function require neurobeachin. Nat Commun 2011,2,557","journal-title":"Nat Commun"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1523\/JNEUROSCI.4644-03.2004","volume":"24","author":"Su Y.","year":"2004","unstructured":"Su Y.; Balice-Gordon R.J.; Hess D.M.; Landsman D.S.; Minarcik J.; Golden J.; Hurwitz I.; Liebhaber S.A.; Cooke N.E.; Neurobeachin is essential for neuromuscular synaptic transmission. J Neurosci 2004,24(14),3627-3636","journal-title":"J Neurosci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"e16266","DOI":"10.1371\/journal.pone.0016266","volume":"6","author":"Twine N.A.","year":"2011","unstructured":"Twine N.A.; Janitz K.; Wilkins M.R.; Janitz M.; Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer\u2019s disease. PLoS One 2011,6(1),e16266","journal-title":"PLoS One"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnsyn.2018.00028","volume":"10","author":"Repetto D.","year":"2018","unstructured":"Repetto D.; Brockhaus J.; Rhee H.J.; Lee C.; Kilimann M.W.; Rhee J.; Northoff L.M.; Guo W.; Reissner C.; Missler M.; Molecular dissection of neurobeachin function at excitatory synapses. Front Synaptic Neurosci 2018,10,28","journal-title":"Front Synaptic Neurosci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/ar.21026","volume":"292","author":"Glavan G.","year":"2009","unstructured":"Glavan G.; Schliebs R.; Zivin M.; Synaptotagmins in neurodegeneration. Anat Rec (Hoboken) 2009,292(12),1849-1862","journal-title":"Anat Rec (Hoboken)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"a011353","DOI":"10.1101\/cshperspect.a011353","volume":"4","author":"S&#xFC;dhof T.C.","year":"2012","unstructured":"S&#xFC;dhof T.C.; Calcium control of neurotransmitter release. Cold Spring Harb Perspect Biol 2012,4(1),a011353","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neuron.2007.05.004","volume":"54","author":"Xu J.","year":"2007","unstructured":"Xu J.; Mashimo T.; S&#xFC;dhof T.C.; Synaptotagmin-1, -2, and -9: Ca(2+) sensors for fast release that specify distinct presynaptic properties in subsets of neurons. Neuron 2007,54(4),567-581","journal-title":"Neuron"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/0014-5793(95)00176-A","volume":"361","author":"Craxton M.","year":"1995","unstructured":"Craxton M.; Goedert M.; Synaptotagmin V.; Synaptotagmin V: a novel synaptotagmin isoform expressed in rat brain. FEBS Lett 1995,361(2-3),196-200","journal-title":"FEBS Lett"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-015-0028-5","volume":"10","author":"Gautam V.","year":"2015","unstructured":"Gautam V.; D\u2019Avanzo C.; Berezovska O.; Tanzi R.E.; Kovacs D.M.; Synaptotagmins interact with APP and promote A&#x3B2; generation. Mol Neurodegener 2015,10,31","journal-title":"Mol Neurodegener"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/cm.20388","volume":"66","author":"Bamburg J.R.","year":"2009","unstructured":"Bamburg J.R.; Bloom G.S.; Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton 2009,66(8),635-649","journal-title":"Cell Motil Cytoskeleton"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"e2750","DOI":"10.1371\/journal.pone.0002750","volume":"3","author":"Martin B.","year":"2008","unstructured":"Martin B.; Brenneman R.; Becker K.G.; Gucek M.; Cole R.N.; Maudsley S.; iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer\u2019s mice: understanding the interface between physiology and disease. PLoS One 2008,3(7),e2750","journal-title":"PLoS One"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/path.5254","volume":"248","author":"Bossenmeyer-Pouri&#xE9; C.","year":"2019","unstructured":"Bossenmeyer-Pouri&#xE9; C.; Smith A.D.; Lehmann S.; Deramecourt V.; Sablonni&#xE8;re B.; Camadro J.M.; Pouri&#xE9; G.; Kerek R.; Helle D.; Umoret R.; Gu&#xE9;ant-Rodriguez R.M.; Rigau V.; Gabelle A.; Sequeira J.M.; Quadros E.V.; Daval J.L.; Gu&#xE9;ant J.L.; N-homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer\u2019s disease and vascular dementia. J Pathol 2019,248(3),291-303","journal-title":"J Pathol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"Giasson B.I.","year":"2003","unstructured":"Giasson B.I.; Forman M.S.; Higuchi M.; Golbe L.I.; Graves C.L.; Kotzbauer P.T.; Trojanowski J.Q.; Lee V.M-Y.; Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003,300(5619),636-640","journal-title":"Science"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.semcdb.2018.05.005","volume":"99","author":"Yan X.","year":"2020","unstructured":"Yan X.; Uronen R.L.; Huttunen H.J.; The interaction of &#x3B1;-synuclein and Tau: A molecular conspiracy in neurodegeneration? Semin Cell Dev Biol 2020,99,55-64","journal-title":"Semin Cell Dev Biol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0278-5846(02)00339-1","volume":"27","author":"Wirths O.","year":"2003","unstructured":"Wirths O.; Bayer T.A.; &#x3B1;-synuclein, Abeta and Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 2003,27(1),103-108","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/glia.20909","volume":"58","author":"Lehotzky A.","year":"2010","unstructured":"Lehotzky A.; Lau P.; Tok&#xE9;si N.; Muja N.; Hudson L.D.; Ov&#xE1;di J.; Tubulin polymerization-promoting protein (TPPP\/p25) is critical for oligodendrocyte differentiation. Glia 2010,58(2),157-168","journal-title":"Glia"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"34088","DOI":"10.1074\/jbc.M111.243907","volume":"286","author":"Ol&#xE1;h J.","year":"2011","unstructured":"Ol&#xE1;h J.; Vincze O.; Vir&#xF3;k D.; Simon D.; Bozs&#xF3; Z.; T&#xF5;k&#xE9;si N.; Horv&#xE1;th I.; Hlavanda E.; Kov&#xE1;cs J.; Magyar A.; Sz\u0169cs M.; Orosz F.; Penke B.; Ov&#xE1;di J.; Interactions of pathological hallmark proteins: tubulin polymerization promoting protein\/p25, &#x3B2;-amyloid, and &#x3B1;-synuclein. J Biol Chem 2011,286(39),34088-34100","journal-title":"J Biol Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"13976","DOI":"10.1073\/pnas.2436331100","volume":"100","author":"Tiri&#xE1;n L.","year":"2003","unstructured":"Tiri&#xE1;n L.; Hlavanda E.; Ol&#xE1;h J.; Horv&#xE1;th I.; Orosz F.; Szab&#xF3; B.; Kov&#xE1;cs J.; Szabad J.; Ov&#xE1;di J.; TPPP\/p25 promotes tubulin assemblies and blocks mitotic spindle formation. Proc Natl Acad Sci USA 2003,100(24),13976-13981","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/JAD-2002-4402","volume":"4","author":"Grant P.","year":"2002","unstructured":"Grant P.; Pant H.C.; Topographic regulation of kinase activity in Alzheimer\u2019s disease brains. J Alzheimers Dis 2002,4(4),269-281","journal-title":"J Alzheimers Dis"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40478-018-0574-5","volume":"6","author":"Maziuk B.F.","year":"2018","unstructured":"Maziuk B.F.; Apicco D.J.; Cruz A.L.; Jiang L.; Ash P.E.A.; da Rocha E.L.; Zhang C.; Yu W.H.; Leszyk J.; Abisambra J.F.; Li H.; Wolozin B.; RNA binding proteins co-localize with small tau inclusions in tauopathy. Acta Neuropathol Commun 2018,6(1),71","journal-title":"Acta Neuropathol Commun"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0169-328X(97)00343-4","volume":"54","author":"David S.","year":"1998","unstructured":"David S.; Shoemaker M.; Haley B.E.; Abnormal properties of creatine kinase in Alzheimer\u2019s disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. Brain Res Mol Brain Res 1998,54(2),276-287","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1006859632730","volume":"184","author":"Dzeja P.P.","year":"1998","unstructured":"Dzeja P.P.; Zeleznikar R.J.; Goldberg N.D.; Adenylate kinase: kinetic behavior in intact cells indicates it is integral to multiple cellular processes. Mol Cell Biochem 1998,184(1-2),169-182","journal-title":"Mol Cell Biochem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1590\/0001-3765201620150776","volume":"88","author":"Ianiski F.R.","year":"2016","unstructured":"Ianiski F.R.; Rech V.C.; Nishihira V.S.K.; Alves C.B.; Baldissera M.D.; Wilhelm E.A.; Luchese C.; Amyloid-&#x3B2; peptide absence in short term effects on kinase activity of energy metabolism in mice hippocampus and cerebral cortex. An Acad Bras Cienc 2016,88(3 Suppl),1829-1840","journal-title":"An Acad Bras Cienc"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/hmg\/dds100","volume":"21","author":"Park H.","year":"2012","unstructured":"Park H.; Kam T.I.; Kim Y.; Choi H.; Gwon Y.; Kim C.; Koh J.Y.; Jung Y.K.; Neuropathogenic role of adenylate kinase-1 in A&#x3B2;-mediated tau phosphorylation via AMPK and GSK3&#x3B2;. Hum Mol Genet 2012,21(12),2725-2737","journal-title":"Hum Mol Genet"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2017.08.035","volume":"663","author":"Strehler E.E.","year":"2018","unstructured":"Strehler E.E.; Thayer S.A.; Evidence for a role of plasma membrane calcium pumps in neurodegenerative disease: Recent developments. Neurosci Lett 2018,663,39-47","journal-title":"Neurosci Lett"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1096\/fj.08-121459","volume":"23","author":"Berrocal M.","year":"2009","unstructured":"Berrocal M.; Marcos D.; Sep&#xFA;lveda M.R.; P&#xE9;rez M.; &#xC1;vila J.; Mata A.M.; Altered Ca\n dependence of synaptosomal plasma membrane Ca\n-ATPase in human brain affected by Alzheimer\u2019s disease. FASEB J 2009,23(6),1826-1834","journal-title":"FASEB J"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.tcb.2010.10.003","volume":"21","author":"Naslavsky N.","year":"2011","unstructured":"Naslavsky N.; Caplan S.; EHD proteins: key conductors of endocytic transport. Trends Cell Biol 2011,21(2),122-131","journal-title":"Trends Cell Biol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.celrep.2013.12.006","volume":"5","author":"Buggia-Pr&#xE9;vot V.","year":"2013","unstructured":"Buggia-Pr&#xE9;vot V.; Fernandez C.G.; Udayar V.; Vetrivel K.S.; Elie A.; Roseman J.; Sasse V.A.; Lefkow M.; Meckler X.; Bhattacharyya S.; George M.; Kar S.; Bindokas V.P.; Parent A.T.; Rajendran L.; Band H.; Vassar R.; Thinakaran G.; A function for EHD family proteins in unidirectional retrograde dendritic transport of BACE1 and Alzheimer\u2019s disease A&#x3B2; production. Cell Rep 2013,5(6),1552-1563","journal-title":"Cell Rep"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"16798","DOI":"10.1074\/jbc.M110.113753","volume":"285","author":"Jinwal U.K.","year":"2010","unstructured":"Jinwal U.K.; O\u2019Leary J.C.; Borysov S.I.; Jones J.R.; Li Q.; Koren J.; Abisambra J.F.; Vestal G.D.; Lawson L.Y.; Johnson A.G.; Blair L.J.; Jin Y.; Miyata Y.; Gestwicki J.E.; Dickey C.A.; Hsc70 rapidly engages tau after microtubule destabilization. J Biol Chem 2010,285(22),16798-16805","journal-title":"J Biol Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1073\/pnas.242720499","volume":"100","author":"Dou F.","year":"2003","unstructured":"Dou F.; Netzer W.J.; Tanemura K.; Li F.; Hartl F.U.; Takashima A.; Gouras G.K.; Greengard P.; Xu H.; Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci USA 2003,100(2),721-726","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"33182","DOI":"10.1074\/jbc.M606192200","volume":"281","author":"Evans C.G.","year":"2006","unstructured":"Evans C.G.; Wis&#xE9;n S.; Gestwicki J.E.; Heat shock proteins 70 and 90 inhibit early stages of amyloid &#x3B2;-(1-42) aggregation in vitro.\n J Biol Chem 2006,281(44),33182-33191","journal-title":"J Biol Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/JAD-130779","volume":"38","author":"Bobkova N.V.","year":"2014","unstructured":"Bobkova N.V.; Garbuz D.G.; Nesterova I.; Medvinskaya N.; Samokhin A.; Alexandrova I.; Yashin V.; Karpov V.; Kukharsky M.S.; Ninkina N.N.; Smirnov A.A.; Nudler E.; Evgen\u2019ev M.; Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer\u2019s disease. J Alzheimers Dis 2014,38(2),425-435","journal-title":"J Alzheimers Dis"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"25497","DOI":"10.1074\/jbc.M400255200","volume":"279","author":"Klucken J.","year":"2004","unstructured":"Klucken J.; Shin Y.; Masliah E.; Hyman B.T.; McLean P.J.; Hsp70 Reduces &#x3B1;-synuclein aggregation and toxicity. J Biol Chem 2004,279(24),25497-25502","journal-title":"J Biol Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","volume":"99","author":"Eftekharzadeh B.","year":"2018","unstructured":"Eftekharzadeh B.; Daigle J.G.; Kapinos L.E.; Coyne A.; Schiantarelli J.; Carlomagno Y.; Cook C.; Miller S.J.; Dujardin S.; Amaral A.S.; Grima J.C.; Bennett R.E.; Tepper K.; DeTure M.; Vanderburg C.R.; Corjuc B.T.; DeVos S.L.; Gonzalez J.A.; Chew J.; Vidensky S.; Gage F.H.; Mertens J.; Troncoso J.; Mandelkow E.; Salvatella X.; Lim R.Y.H.; Petrucelli L.; Wegmann S.; Rothstein J.D.; Hyman B.T.; Tau protein disrupts nucleocytoplasmic transport in Alzheimer\u2019s disease. Neuron 2018,99(5),925-940.e7","journal-title":"Neuron"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1039\/B715278G","volume":"4","author":"Sultana R.","year":"2008","unstructured":"Sultana R.; Butterfield D.A.; Alterations of some membrane transport proteins in Alzheimer\u2019s disease: role of amyloid &#x3B2;-peptide. Mol Biosyst 2008,4(1),36-41","journal-title":"Mol Biosyst"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.biochem.75.103004.142637","volume":"75","author":"Stokin G.B.","year":"2006","unstructured":"Stokin G.B.; Goldstein L.S.B.; Axonal transport and Alzheimer\u2019s disease. Annu Rev Biochem 2006,75,607-627","journal-title":"Annu Rev Biochem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"34674","DOI":"10.1074\/jbc.M402324200","volume":"279","author":"Brown J.","year":"2004","unstructured":"Brown J.; Theisler C.; Silberman S.; Magnuson D.; Gottardi-Littell N.; Lee J.M.; Yager D.; Crowley J.; Sambamurti K.; Rahman M.M.; Reiss A.B.; Eckman C.B.; Wolozin B.; Differential expression of cholesterol hydroxylases in Alzheimer\u2019s disease. J Biol Chem 2004,279(33),34674-34681","journal-title":"J Biol Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1326-3-5","volume":"3","author":"Zerbinatti C.V.","year":"2008","unstructured":"Zerbinatti C.V.; Cordy J.M.; Chen C.D.; Guillily M.; Suon S.; Ray W.J.; Seabrook G.R.; Abraham C.R.; Wolozin B.; Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein. Mol Neurodegener 2008,3,5","journal-title":"Mol Neurodegener"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/hmg\/10.17.1753","volume":"10","author":"Lin W-H.","year":"2001","unstructured":"Lin W-H.; Chiu K.C.; Chang H.M.; Lee K.C.; Tai T.Y.; Chuang L.M.; Molecular scanning of the human sorbin and SH3-domain-containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 diabetes. Hum Mol Genet 2001,10(17),1753-1760","journal-title":"Hum Mol Genet"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"10574","DOI":"10.1038\/s41598-018-28891-z","volume":"8","author":"Chang T.J.","year":"2018","unstructured":"Chang T.J.; Wang W.C.; Hsiung C.A.; He C.T.; Lin M.W.; Sheu W.H.H.; Chang Y.C.; Quertermous T.; Chen Y.I.; Rotter J.I.; Chuang L.M.; Hwu C.M.; Hung Y.J.; Lee W.J.; Te Lee I.; Genetic variation of SORBS1 gene is associated with glucose homeostasis and age at onset of diabetes: A SAPPHIRe Cohort Study. Sci Rep 2018,8(1),10574","journal-title":"Sci Rep"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-018-0524-2","volume":"6","author":"Zhang Q.","year":"2018","unstructured":"Zhang Q.; Ma C.; Gearing M.; Wang P.G.; Chin L.S.; Li L.; Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer\u2019s disease. Acta Neuropathol Commun 2018,6(1),19","journal-title":"Acta Neuropathol Commun"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1128\/MCB.00775-15","volume":"36","author":"Hallock P.T.","year":"2015","unstructured":"Hallock P.T.; Chin S.; Blais S.; Neubert T.A.; Glass D.J.; Sorbs1 and -2 interact with CrkL and are required for acetylcholine receptor cluster formation. Mol Cell Biol 2015,36(2),262-270","journal-title":"Mol Cell Biol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1128\/MCB.01109-06","volume":"27","author":"Limpert A.S.","year":"2007","unstructured":"Limpert A.S.; Karlo J.C.; Landreth G.E.; Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signal-regulated kinase activation through c-Cbl-associated protein. Mol Cell Biol 2007,27(16),5686-5698","journal-title":"Mol Cell Biol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.3233\/JAD-180496","volume":"70","author":"Wan Nasri W.N.","year":"2019","unstructured":"Wan Nasri W.N.; Makpol S.; Mazlan M.; Tooyama I.; Wan Ngah W.Z.; Damanhuri H.A.; Tocotrienol rich fraction supplementation modulate brain hippocampal gene expression in APPswe\/PS1dE9 Alzheimer\u2019s disease mouse model. J Alzheimers Dis 2019,70(s1),S239-S254","journal-title":"J Alzheimers Dis"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1172\/JCI38003","volume":"119","author":"Liem R.K.H.","year":"2009","unstructured":"Liem R.K.H.; Messing A.; Dysfunctions of neuronal and glial intermediate filaments in disease. J Clin Invest 2009,119(7),1814-1824","journal-title":"J Clin Invest"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0197-4580(01)00307-4","volume":"22","author":"Meda L.","year":"2001","unstructured":"Meda L.; Baron P.; Scarlato G.; Glial activation in Alzheimer\u2019s disease: the role of Abeta and its associated proteins. Neurobiol Aging 2001,22(6),885-893","journal-title":"Neurobiol Aging"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0197-4580(02)00090-8","volume":"24","author":"Vehmas A.K.","year":"2003","unstructured":"Vehmas A.K.; Kawas C.H.; Stewart W.F.; Troncoso J.C.; Immune reactive cells in senile plaques and cognitive decline in Alzheimer\u2019s disease. Neurobiol Aging 2003,24(2),321-331","journal-title":"Neurobiol Aging"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnint.2016.00031","volume":"10","author":"Hertz L.","year":"2016","unstructured":"Hertz L.; Chen Y.; Simon S.A.; Gutierrez R.; Tandon S.; Editorial: all 3 types of glial cells are important for memory formation. Front Integr Nuerosci 2016,10,31","journal-title":"Front Integr Nuerosci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.neuroscience.2007.02.055","volume":"147","author":"Glezer I.","year":"2007","unstructured":"Glezer I.; Simard A.R.; Rivest S.; Neuroprotective role of the innate immune system by microglia. Neuroscience 2007,147(4),867-883","journal-title":"Neuroscience"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1440-1827.1998.tb03915.x","volume":"48","author":"Kato S.","year":"1998","unstructured":"Kato S.; Gondo T.; Hoshii Y.; Takahashi M.; Yamada M.; Confocal observation of senile plaques in Alzheimer\u2019s disease&#x202F;: Senile plaque morphology and relationship between senile plaques and astrocytes. 1998,48(5),332-340"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2013.12.071","volume":"565","author":"Pekny M.","year":"2014","unstructured":"Pekny M.; Wilhelmsson U.; Pekna M.; The dual role of astrocyte activation and reactive gliosis. Neurosci Lett 2014,565,30-38","journal-title":"Neurosci Lett"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","volume":"16","author":"Fakhoury M.","year":"2018","unstructured":"Fakhoury M.; Microglia and astrocytes in Alzheimer\u2019s disease: implications for therapy. Curr Neuropharmacol 2018,16(5),508-518","journal-title":"Curr Neuropharmacol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/pmic.200300456","volume":"3","author":"Porchet R.","year":"2003","unstructured":"Porchet R.; Probst A.; Bouras C.; Dr&#xE1;berov&#xE1; E.; Dr&#xE1;ber P.; Riederer B.M.; Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer\u2019s disease. Proteomics 2003,3(8),1476-1485","journal-title":"Proteomics"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1440-1819.1998.tb02706.x","volume":"52","author":"Muramori F.","year":"1998","unstructured":"Muramori F.; Kobayashi K.; Nakamura I.; A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer\u2019s disease, normal controls and non-Alzheimer neuropsychiatric diseases. Psychiatry Clin Neurosci 1998,52(6),593-599","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-180325","volume":"67","author":"Oeckl P.","year":"2019","unstructured":"Oeckl P.; Halbgebauer S.; Anderl-Straub S.; Steinacker P.; Huss A.M.; Neugebauer H.; von Arnim C.A.F.; Diehl-Schmid J.; Grimmer T.; Kornhuber J.; Lewczuk P.; Danek A.; Ludolph A.C.; Otto M.; Otto M.; Consortium for frontotemporal lobar degeneration german. Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment. J Alzheimers Dis 2019,67(2),481-488","journal-title":"J Alzheimers Dis"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cardiores.2003.12.009","volume":"62","author":"Giepmans B.N.G.","year":"2004","unstructured":"Giepmans B.N.G.; Gap junctions and connexin-interacting proteins. Cardiovasc Res 2004,62(2),233-245","journal-title":"Cardiovasc Res"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fncel.2014.00189","volume":"8","author":"Takeuchi H.","year":"2014","unstructured":"Takeuchi H.; Suzumura A.; Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases. Front Cell Neurosci 2014,8,189","journal-title":"Front Cell Neurosci"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4103\/1673-5374.155444","volume":"10","author":"Xie H.Y.","year":"2015","unstructured":"Xie H.Y.; Cui Y.; Deng F.; Feng J.C.; Connexin: a potential novel target for protecting the central nervous system? Neural Regen Res 2015,10(4),659-666","journal-title":"Neural Regen Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.bbamem.2011.10.001","volume":"1818","author":"Koulakoff A.","year":"2012","unstructured":"Koulakoff A.; Mei X.; Orellana J.A.; S&#xE1;ez J.C.; Giaume C.; Glial connexin expression and function in the context of Alzheimer\u2019s disease. Biochim Biophys Acta 2012,1818(8),2048-2057","journal-title":"Biochim Biophys Acta"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0006-8993(95)01526-4","volume":"717","author":"Nagy J.I.","year":"1996","unstructured":"Nagy J.I.; Li W.; Hertzberg E.L.; Marotta C.A.; Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer\u2019s disease. Brain Res 1996,717(1-2),173-178","journal-title":"Brain Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.lfs.2018.07.033","volume":"208","author":"Ren R.","year":"2018","unstructured":"Ren R.; Zhang L.; Wang M.; Specific deletion connexin43 in astrocyte ameliorates cognitive dysfunction in APP\/PS1 mice. Life Sci 2018,208,175-191","journal-title":"Life Sci"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0014-4886(03)00252-8","volume":"184","author":"Blanchard V.","year":"2003","unstructured":"Blanchard V.; Moussaoui S.; Czech C.; Touchet N.; Bonici B.; Planche M.; Canton T.; Jedidi I.; Gohin M.; Wirths O.; Bayer T.A.; Langui D.; Duyckaerts C.; Tremp G.; Pradier L.; Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP\/PS1 transgenic mice. Exp Neurol 2003,184(1),247-263","journal-title":"Exp Neurol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1016\/j.neurobiolaging.2013.05.003","volume":"34","author":"Saul A.","year":"2013","unstructured":"Saul A.; Sprenger F.; Bayer T.A.; Wirths O.; Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging 2013,34(11),2564-2573","journal-title":"Neurobiol Aging"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327999201116193126","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/188036\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327999201116193126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T13:56:17Z","timestamp":1654437377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/188036\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":145,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327999201116193126","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}